Ventilator-associated Pneumonia Clinical Trial
Official title:
Effectiveness of Different Educational Strategies on the Knowledge, Attitude, and Practice ( KAP), Psychological and Clinical Outcomes in Intensive Care Unit: A Triple-blinded Randomized Controlled Follow-up Study
A randomized controlled triple blinded clinical trial with repeated measurements. The
reporting of this study complies with the CONSORT (Consolidated Standards of Reporting
Trials) statement for trials of non-pharmacological treatments.
The first aim of the study was to evaluate the effectiveness of the three competing
interventions on the critical care nurses' knowledge of, attitudes toward and adherence to
17 ventilator bundle components; the second aim was to determine the effectiveness of
adherence to 17 ventilator bundle components with pre-defined ventilator bundle on the
psychological factors of critical care nurses including nurses' stressors in intensive care
unit (ICU), perceived stress, trait and state anxieties; the third aim was to evaluate their
impact on the clinical outcomes; and the fourth aim was comparing KAP and psychological
factors with clinical outcomes.
The multi-center study was conducted in four academic teaching hospitals in Tehran, Iran.
The study consisted of a 3-month baseline observation period (October 2011-December 2011,
Period 1), followed by a 6-month intervention period (January 2012 to June 2012) and a 3
(July 2012-September 2012, Period 2), 15 (October 2012-December 2013, Period 3) and
21-months (January 2014-June 2015, Period 4) follow-up periods. The protocol for Evidence
based guidelines (EBGs) for preventing VAP remained unchanged throughout the study period in
every ICU.
Consecutive adult patients (age ≥18 years) who were admitted to the mixed medical-surgical
ICUs (>72 hours) and received invasive ventilation (>48 hours) were enrolled and monitored
daily for the development of ventilator-associate pneumonia (VAP) until ICU discharge or
death. Patients with any limitation of code status were excluded from the study. Convenience
sample of critical care nurses were recruited through letters and telephone and face-to-face
invitations. Inclusion criteria were holding a degree qualification as a registered nurse
and being a direct care provider (bedside). Nurses with less than one year experience in
critical care unit or working less than whole study period were excluded. An investigator at
each participating medical center was responsible for initial screening and enrollment.
The sample size was determined through power analysis, which revealed that a sample size of
40 participants was required to detect a 20% difference between VAP rates in each group (α =
0.05, 1-β = 0.9; dropout = 20%). The estimation of the effect size based on a previous VAP
surveillance, conducted from March 2010 to December 2010 (unpublished data).
Included nurses were randomly assigned to control or one of the three competing intervention
group (allocation ratio of 1:4). Randomization was accomplished using Random Allocation
Software© (RAS; Informer Technologies, Inc.). Block randomization was performed by a
computer-generated randomization list prepared by blinded biostatistician who had no
clinical involvement in the trial. All nurses, data collectors, and statistician were
blinded to group assignment.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01406951 -
Diagnostic Value of sTREM-1 and PCT Level as Well as CPIS Score for Ventilator-Associated Pneumonia Among ICU Sepsis Patients
|
N/A | |
Completed |
NCT00893763 -
Strategies To Prevent Pneumonia 2 (SToPP2)
|
Phase 2 | |
Recruiting |
NCT03581370 -
Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients With Ventilator Associated-pneumonia
|
Phase 3 | |
Completed |
NCT02070757 -
Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)
|
Phase 3 | |
Completed |
NCT03348579 -
Hospital-acquired Pneumonia in Intensive Care Unit
|
||
Completed |
NCT04242706 -
VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs
|
Phase 4 | |
Recruiting |
NCT05589727 -
Application of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified in Brazil
|
||
Not yet recruiting |
NCT06168734 -
Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
|
Phase 3 | |
Completed |
NCT02515448 -
A Pharmacokinetic-pharmacodynamic Dose Comparison Study of 8 mg/kg of Inhaled or Parenteral Gentamicin in 12 Mechanically Ventilated Critically Ill Patients Treated for Ventilator-associated Pneumonia
|
Phase 1 | |
Completed |
NCT01972425 -
Biomarker-based Exclusion of VAP for Improved Antibiotic Stewardship
|
N/A | |
Completed |
NCT01467648 -
The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia
|
Phase 4 | |
Completed |
NCT00364299 -
Prevention of Ventilator-Associated Pneumonia by Automatic Control of the Tracheal Tube Cuff Pressure
|
N/A | |
Not yet recruiting |
NCT03018431 -
CT Scan and Lung Ultrasonography to Improve Diagnostic of Ventilation Acquired Pneumonia in ICU
|
N/A | |
Completed |
NCT02515617 -
Medico-economic Study of the Subglottic Secretions Drainage in Prevention of Ventilator-associated Pneumonia (DEMETER)
|
N/A | |
Completed |
NCT02585180 -
Subglottic Secretions Surveillance to Predict Bacterial Pathogens Involved in Ventilator-associated Pneumonia
|
N/A | |
Completed |
NCT02583308 -
Impact of the Subglottic Secretions Drainage on the Tracheal Secretions Colonisation
|
N/A | |
Recruiting |
NCT01546974 -
Ventilator-associated Pneumonia (VAP) and Humidification System
|
Phase 4 | |
Completed |
NCT02060045 -
Prevention Ventilator Associated Pneumonia
|
N/A | |
Terminated |
NCT00543608 -
Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia
|
Phase 2 | |
Completed |
NCT02116699 -
Oropharyngeal Administration of Mother's Colostrum for Premature Infants (NS-72393-360)
|
N/A |